Search research articles
Contact Us
Filters
Showing results (21-30 of 390) with videos related to
Page
of 39
Sort By:
Current HIV Research
|
March 27, 2025
Fc Functions and Anti-HIV Neutralizing Antibodies: A Perspective
Hillary A Venderven, Stephen J Kent
Current Opinion in HIV and AIDS
|
September 9, 2016
HIV vaccines moving forward
Stephen J Kent, Jerome H Kim
The Lancet. HIV
|
October 2, 2015
Tentative first steps to eradicate latent HIV
Stephen J Kent, Miles P Davenport
Frontiers in Immunology
|
December 11, 2023
Fc-mediated functions and the treatment of severe respiratory viral infections with passive immunotherapy - a balancing act
Hillary A Vanderven, Stephen J Kent
Journal of Virology
|
March 21, 2008
Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects
Ivan Stratov, Amy Chung, Stephen J Kent
Sexual Health
|
March 2, 2013
Azithromycin: more lethal than chloramphenicol?
Ivan Stratov, Justin Denholm, Stephen J Kent
AIDS (London, England)
|
November 15, 2014
The role of HIV-specific antibody-dependent cellular cytotoxicity in HIV prevention and the influence of the HIV-1 Vpu protein
Marit Kramski, Ivan Stratov, Stephen J Kent
Expert Review of Clinical Immunology
|
November 22, 2012
HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality
Vijaya Madhavi, Stephen J Kent, Ivan Stratov
Advances in Virology
|
May 22, 2012
Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development
Gamze Isitman, Ivan Stratov, Stephen J Kent
Virology
|
May 24, 2005
Phenotypic and kinetic analysis of effective simian-human immunodeficiency virus-specific T cell responses in DNA--and fowlpox virus-vaccinated macaques
Ivan Stratov, C Jane Dale, Stephen J Kent
Page
of 39
Search research articles
Search
Showing results (21-30 of 390) with videos related to
Sort By:
Page
of 39
Current HIV Research
|
March 27, 2025
Fc Functions and Anti-HIV Neutralizing Antibodies: A Perspective
Hillary A Venderven, Stephen J Kent
Current Opinion in HIV and AIDS
|
September 9, 2016
HIV vaccines moving forward
Stephen J Kent, Jerome H Kim
The Lancet. HIV
|
October 2, 2015
Tentative first steps to eradicate latent HIV
Stephen J Kent, Miles P Davenport
Frontiers in Immunology
|
December 11, 2023
Fc-mediated functions and the treatment of severe respiratory viral infections with passive immunotherapy - a balancing act
Hillary A Vanderven, Stephen J Kent
Journal of Virology
|
March 21, 2008
Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects
Ivan Stratov, Amy Chung, Stephen J Kent
Sexual Health
|
March 2, 2013
Azithromycin: more lethal than chloramphenicol?
Ivan Stratov, Justin Denholm, Stephen J Kent
AIDS (London, England)
|
November 15, 2014
The role of HIV-specific antibody-dependent cellular cytotoxicity in HIV prevention and the influence of the HIV-1 Vpu protein
Marit Kramski, Ivan Stratov, Stephen J Kent
Expert Review of Clinical Immunology
|
November 22, 2012
HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality
Vijaya Madhavi, Stephen J Kent, Ivan Stratov
Advances in Virology
|
May 22, 2012
Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development
Gamze Isitman, Ivan Stratov, Stephen J Kent
Virology
|
May 24, 2005
Phenotypic and kinetic analysis of effective simian-human immunodeficiency virus-specific T cell responses in DNA--and fowlpox virus-vaccinated macaques
Ivan Stratov, C Jane Dale, Stephen J Kent
Page
of 39